Gynecomastia Risk Factors and Assessment

Primary Risk Factors

The American College of Physicians recommends considering hormonal disorders, such as hyperprolactinemia, as a risk factor for gynecomastia 1
Liver cirrhosis is a systemic disease that increases the risk of gynecomastia, according to the Annals of Oncology 2
Klinefelter syndrome significantly increases the risk of gynecomastia, with a relative risk of 24.7, as reported by the Annals of Oncology 3
Obesity contributes to pseudogynecomastia but can also increase true gynecomastia through peripheral conversion of androgens to estrogens, according to Praxis Medical Insights 1
Pre-existing gynecomastia increases the risk of further development, as stated by Praxis Medical Insights 1

BRCA2 mutation carriers have a significantly higher risk of male breast cancer and gynecomastia, according to the Annals of Oncology 3
Family history of male breast disorders increases the risk of gynecomastia, as reported by the Annals of Oncology 2

Evaluating medication history, including temporal relationship between medication initiation and onset of gynecomastia, is crucial in assessing gynecomastia risk, according to Praxis Medical Insights 1
Assessing for underlying medical conditions, such as hypogonadism, thyroid disease, liver disease, or renal dysfunction, is essential in gynecomastia evaluation, as stated by Praxis Medical Insights 1
Considering genetic factors, such as family history of breast disorders, is vital in gynecomastia risk assessment, according to the Annals of Oncology 2 and 3
Differentiating true gynecomastia from pseudogynecomastia is crucial in gynecomastia evaluation, as reported by Praxis Medical Insights 1

The risk of male breast cancer is higher in patients with BRCA2 mutations and Klinefelter syndrome, according to the Annals of Oncology 3
Early identification of underlying causes allows for targeted intervention, and gynecomastia persisting beyond 12 months often becomes fibrotic and less responsive to medical therapy, as stated by Praxis Medical Insights 1

Failing to distinguish between true gynecomastia and pseudogynecomastia, especially in obese patients, is a common pitfall, according to Praxis Medical Insights 1
Unnecessary imaging in clear cases of gynecomastia can lead to additional unnecessary benign biopsies, as reported by Praxis Medical Insights 1

Adrenal tumors can secrete estrogen directly, causing gynecomastia, according to the National Comprehensive Cancer Network 4
Adrenocortical carcinomas may secrete estrogen directly, contributing to gynecomastia, as reported by the National Comprehensive Cancer Network 4
Chemotherapeutic agents are known to cause gynecomastia, as stated by the National Comprehensive Cancer Network 4